The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
Open accessAbstract
Injury or impaired clearance of apoptotic cells leads to the pathological accumulation of necrotic corpses, which induce an inflammatory response that initiates tissue repair. In addition, antigens present in necrotic cells can sometimes provoke a specific immune response and it has been argued that necrosis could explain adaptive immunity in seemingly infection-free situations, such as after allograft transplantation or in spontaneous and therapy-induced tumour rejection. In the mouse, the CD8alpha+ subset of dendritic cells phagocytoses dead cell remnants and cross-primes CD8+ T cells against cell-associated antigens. Here we show that CD8alpha+ dendritic cells use CLEC9A (also known as DNGR-1), a recently-characterized C-type lectin, to recognize a preformed signal that is exposed on necrotic cells. Loss or blockade of CLEC9A does not impair the uptake of necrotic cell material by CD8+ dendritic cells, but specifically reduces cross-presentation of dead-cell-associated antigens in vitro and decreases the immunogenicity of necrotic cells in vivo. The function of CLEC9A requires a key tyrosine residue in its intracellular tail that allows the recruitment and activation of the tyrosine kinase SYK, which is also essential for cross-presentation of dead-cell-associated antigens. Thus, CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of caspases, a specific class of cysteine proteases has multiple effects on the immunogenicity of cell death 56”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis has traditionally been considered merely as an accidental, uncontrolled form of cell death that only occurs in pathological circumstances.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“There are several distinct subtypes of apoptosis that, although morphologically similar, can be triggered through different biochemical routes (for example, through the intrinsic or the extrinsic pathway or with or without caspase activation).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Autophagic cell death occurs in the absence of chromatin condensation but is accompanied by massive autophagic vacuolization of the cytoplasm.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Apoptosis is accompanied by rounding-up of the cell, retraction of pseudopods, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), few or no ultrastructural modifications of cytoplasmic organelles, and plasma membrane blebbing but cell integrity is maintained until the final stages of the process.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Furthermore, the apparent uniformity of apoptotic cell death may conceal heterogeneous functional aspects, such as whether or not dying apoptotic cells are recognized by the immune system 56.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“CLeC9A has been shown to recognize necrotic cells and induce the cross-presentation of dead cell-associated antigens to CD8+ T cells.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
In the citing paper
“Therefore, it may be involved in regulating sterile immune responses, although the specific ligand recognized in this case is still unknown73,75.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Sauter, B., Albert, M. L., Francisco, L. M., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,357
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 750
DCs at the center of help: Origins and evolution of the three-cell-type hypothesis
Wu, R., & MURPHY, K. M. M. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211519 · Cited by 52
The pathophysiological role of dendritic cell subsets in psoriasis
Kim, T., Kim, D. S., Kim, H., & Lee, M. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.014 · Cited by 50
In vivo depletion of DC impairs the anti‐tumor effect of agonistic anti‐CD137 mAb
Murillo, O., Dubrot, J., Palazón, A., Arina, A., Azpilikueta, A., Alfaro, C., Solano, S., Ochoa, M. C., Berasain, C., Gabari, I., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838958 · Cited by 51
Inflammasome activation in response to dead cells and their metabolites
Kono, H., Kimura, Y., & Latz, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.09.001 · Cited by 52
Human Dendritic Cells: Ontogeny and Their Subsets in Health and Disease
Solano, S., Tovar-Torres, S. M., Tron-Gomez, M. S., Smeke, A. E. W., Álvarez-Hernández, D.-A., Kelly, G. A. F., Moreno, M. A. T., Ibarra, A., Gutiérrez‐Kobeh, L., & Vázquez-López, R. (2018) · Medical Sciences · doi:10.3390/medsci6040088 · Cited by 51
Ueki, H., Wang, I.-H., Zhao, D., Gunzer, M., & Kawaoka, Y. (2020) · Nature Protocols · doi:10.1038/s41596-019-0275-y · Cited by 52
Tang, X., Wen, Y., Zhang, Z., Zhu, J., Song, X., & Li, J. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121207 · Cited by 50
Dutertre, C., Jourdain, J.-P., Rancez, M., Amraoui, S., Fossum, E., Bogen, B., Sanchez, C., Couëdel-Courteille, A., Richard, Y., Dalod, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302448 · Cited by 55
Innate immune sensing of cancer: clues from an identified role for type I IFNs
Gajewski, T. F., Fuertes, M. B., & Woo, S. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1305-6 · Cited by 52
Minoda, Y., Virshup, I., Rojas, I. L., Haigh, O. L., Wong, Y., Miles, J. J., Wells, C. A., & Radford, K. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01419 · Cited by 50
Talker, S. C., Baumann, A., Barut, G. T., Keller, I., Bruggmann, R., & Summerfield, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02505 · Cited by 47
Shaping of T Cell Functions by Trogocytosis
NAKAYAMA, M., Hori, A., Toyoura, S., & Yamaguchi, S.-I. (2021) · Cells · doi:10.3390/cells10051155 · Cited by 55
A purine metabolic checkpoint that prevents autoimmunity and autoinflammation
Saveljeva, S., Sewell, G. W., Ramshorn, K., Cader, M. Z., West, J. A., Clare, S., Haag, L.-M., Rodrigues, R. P. D. A., Unger, L. W., Iglesias-Romero, A. B., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.009 · Cited by 51
Regulation of the tolerogenic function of steady‐state DCs
Probst, H. C., Muth, S., & Schild, H. (2014) · European Journal of Immunology · doi:10.1002/eji.201343862 · Cited by 51
Cell death programs in Yersinia immunity and pathogenesis
Philip, N. H., & Brodsky, I. E. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00149 · Cited by 45
Harnessing Human Cross-Presenting CLEC9A+XCR1+ Dendritic Cells for Immunotherapy
Tullett, K. M., Lahoud, M. H., & Radford, K. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00239 · Cited by 49
Korenfeld, D., Gorvel, L., Munk, A., Man, J. J., Schaffer, A., Tung, T., Mann, C. M., & Klechevsky, E. (2017) · JCI Insight · doi:10.1172/jci.insight.96101 · Cited by 48
Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
Gilabert‐Oriol, R., Ryan, G. M., Leung, A. W. Y., Firmino, N. S., Bennewith, K. L., & Bally, M. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102922 · Cited by 53
A myriad of roles of dendritic cells in atherosclerosis
Zhao, Y., Zhang, J., Zhang, W., & Xu, Y. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13634 · Cited by 49
Pyroptosis and the cellular consequences of gasdermin pores
Huston, H. C., Anderson, M. J., & Fink, S. L. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101803 · Cited by 53
Cao, L., Chang, H., Shi, X., Peng, C., & He, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609331113 · Cited by 48
Targeting dendritic cells to advance cross-presentation and vaccination outcomes
Macri, C., Jenika, D., Ouslinis, C., & Mintern, J. D. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101762 · Cited by 50
Bieber, K., & Autenrieth, S. E. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.10.025 · Cited by 48
Compeer, E., Flinsenberg, T., van der Grein, S. G., & Boes, M. (2012) · Front. Immun. · doi:10.3389/fimmu.2012.00037 · Cited by 47
Hutten, T. J. A., Thordardottir, S., Fredrix, H., Janssen, L. M. A., Woestenenk, R., Tel, J., Joosten, B., Cambi, A., Heemskerk, M. H. M., Franssen, G. M., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600011 · Cited by 47
Dendritic cells in central nervous system autoimmunity
Sie, C., & Korn, T. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0608-7 · Cited by 47
Yang, Z., Li, Q., Wang, X., Jiang, X., Zhao, D., Lin, X., He, F., & Tang, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804094115 · Cited by 46
Cueto, F. J., del Fresno, C., Brandi, P., Combes, A. J., Hernández-García, E., Sánchez-Paulete, A. R., Enamorado, M., Bromley, C. P., Gómez, M. J., Conde‐Garrosa, R., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002054 · Cited by 48
Self-citationCell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity
Ladoire, S., Hannani, D., Vétizou, M., Locher, C., Aymeric, L., Apétoh, L., Kepp, O., Kroemer, G., Ghiringhelli, F., & Zitvogel, L. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5133 · Cited by 50
Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3−/− mice
Caminschi, I., Vremec, D., Ahmet, F., Lahoud, M. H., Villadangos, J. A., MURPHY, K. M. M., Heath, W. R., & Shortman, K. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.11.008 · Cited by 46
Self and nonself recognition through C-type lectin receptor, Mincle
Miyake, Y., Ishikawa, E., Ishikawa, T., & Yamasaki, S. (2010) · Self/Nonself · doi:10.4161/self.1.4.13736 · Cited by 46
Muth, S., Schütze, K., Schild, H., & Probst, H. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110620109 · Cited by 46
Mechanisms and Consequences of Injury and Repair in Older Organ Transplants
Slegtenhorst, B. R., Dor, F. J. M. F., Elkhal, A., Biefer, H. R. C., Yang, X., Edtinger, K., Quante, M., Chong, A. S., & Tullius, S. G. (2014) · Transplantation · doi:10.1097/tp.0000000000000072 · Cited by 45
Mannose receptor is highly expressed by peritoneal dendritic cells in endometriosis
Izumi, G., Koga, K., Takamura, M., Makabe, T., Nagai, M., Urata, Y., Harada, M., Hirata, T., Hirota, Y., Fujii, T., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.036 · Cited by 45
Type 1 conventional dendritic cells: ontogeny, function, and emerging roles in cancer immunotherapy
Zhang, S., Chopin, M., & Nutt, S. L. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.10.004 · Cited by 45
The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice
Haddad, Y., Lahoute, C., Clément, M., Laurans, L., Metghalchi, S., Zeboudj, L., Giraud, A., Loyer, X., Vandestienne, M., Wain‐Hobson, J., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310960 · Cited by 44
HemITAM: A single tyrosine motif that packs a punch
Bauer, B., & Steinle, A. (2017) · Science Signaling · doi:10.1126/scisignal.aan3676 · Cited by 46
Human Tumor-Infiltrating Dendritic Cells: From In Situ Visualization to High-Dimensional Analyses
Hubert, M., Gobbini, É., Bendriss‐Vermare, N., Caux, C., & Valladeau‐Guilemond, J. (2019) · Cancers · doi:10.3390/cancers11081082 · Cited by 45
Gou, S., Wang, S., Liu, W., Chen, G., Zhang, D., Du, J., Yan, Z., Wang, H., Zhai, W., Sui, X., et al. (2021) · Theranostics · doi:10.7150/thno.56406 · Cited by 43
Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers
Frenz, T., Grabski, E., Durán, V., Hozsa, C., Stępczyńska, A., Furch, M., Gieseler, R. K. H., & Kalinke, U. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.008 · Cited by 44
León, B., & Lund, F. E. (2019) · Immunological Reviews · doi:10.1111/imr.12758 · Cited by 46
Thioesterase PPT1 balances viral resistance and efficient T cell crosspriming in dendritic cells
Ou, P., Wen, L., Liu, X., Huang, J., Huang, X., Su, C., Wang, L., Ni, H., Reizis, B., & Yang, C. Y. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190041 · Cited by 42
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells
Lim, K. P. H., Milne, P., Poidinger, M., Duan, K., Lin, H., McGovern, N. N., Abhyankar, H. A., Zinn, D., Burke, T. M., Eckstein, O. S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000488 · Cited by 44
Masterman, K., Haigh, O. L., Tullett, K. M., Rojas, I. L., Walpole, C., Pearson, F. E., Cebon, J. S., Schmidt, C., O’Brien, L., Rosendahl, N., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000691 · Cited by 43
Once upon a prime: DCs shape cancer immunity
Zagorulya, M., & Spranger, S. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.10.006 · Cited by 46
Modulation of antigen presentation by intracellular trafficking
Mintern, J. D., Macri, C., & Villadangos, J. A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.006 · Cited by 44
Cross-Presentation of Cell-Associated Antigens by Mouse Splenic Dendritic Cell Populations
Thacker, R. I., & Janssen, E. M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00041 · Cited by 44
Chmielewski, S., Piaszyk-Borychowska, A., Wesoły, J., & Bluyssen, H. A. R. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1087519 · Cited by 43
Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses
Tesfaye, D. Y., Gudjonsson, A., Bogen, B., & Fossum, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01529 · Cited by 41
Molecular Biology of Atherosclerotic Ischemic Strokes
Tuttolomondo, A., Puleo, M. G., Velardo, M., Corpora, F., Daidone, M., & Pinto, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249372 · Cited by 42
Identification of CD8α+ dendritic cells in rainbow trout (Oncorhynchus mykiss) intestine
Soleto, I., Granja, A. G., Simón, R., Morel, E., Díaz‐Rosales, P., & Tafalla, C. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.04.001 · Cited by 41
Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead
Sun, L. J., Zhang, W., Zhao, Y., Wang, F., Liu, S., Liu, L., Zhao, L., Lu, W., Li, M., & Xu, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01456 · Cited by 43
Imaging flow cytometry with a real-time throughput beyond 1,000,000 events per second
Zhou, J., Mei, L., Yu, M., Ma, X., Hou, D., Yin, Z., Liu, X., Ding, Y., Yang, K., Xiao, R., et al. (2025) · Light Science & Applications · doi:10.1038/s41377-025-01754-9 · Cited by 41
Schulz, O., Hanč, P., Böttcher, J. P., Hoogeboom, R., Diebold, S. S., Tolar, P., & Sousa, C. R. E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.038 · Cited by 43
Self-citationOrigin and development of classical dendritic cells
Guermonprez, P., Gerber-Ferder, Y., Vaivode, K., Bourdely, P., & Helft, J. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.08.002 · Cited by 39
Inflammasomes in dendritic cells: Friend or foe?
Hatscher, L., Amon, L., Heger, L., & Dudziak, D. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.04.002 · Cited by 40
Evolution of the C-Type Lectin-Like Receptor Genes of the DECTIN-1 Cluster in the NK Gene Complex
Sattler, S., Ghadially, H., & Hofer, E. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/931386 · Cited by 41
Hemmi, H., Zaidi, N., Wang, B., de Matos, I. G., Fiorese, C. J., Lubkin, A., Zbytnuik, L. D., Suda, K., Zhang, K., Noda, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102541 · Cited by 39
Page, D. B., Hulett, T. W., Hilton, T. L., Hu, H., Urba, W. J., & Fox, B. A. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0130-4 · Cited by 39
Harpur, C. M., Kato, Y., Dewi, S. T., Stankovic, S., Johnson, D. N., Bedoui, S., Whitney, P. G., Lahoud, M. H., Caminschi, I., Heath, W. R., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800218 · Cited by 39
The ontogenetic path of human dendritic cells
Amon, L., Lehmann, C. H. K., Heger, L., Heidkamp, G. F., & Dudziak, D. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.02.010 · Cited by 40
Fine-tuning of T cell responses during infection
Dorhoi, A., & Kaufmann, S. H. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.004 · Cited by 39
Pathak, S. K., Sköld, A. E., Mohanram, V., Persson, C. M., Johansson, U., & Spetz, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336545 · Cited by 39
Holley, C. L., Monteleone, M. M., Fisch, D., Libert, A. E. S., Ju, R. J., Choi, J. H., Condon, N. D., Emming, S., Crawford, J., Lawrence, G. M. E. P., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-02024-3 · Cited by 43
Immunoproteasomes Shape the Transcriptome and Regulate the Function of Dendritic Cells
de Verteuil, D. A., Rouette, A., Hardy, M., Lavallée, S., Trofimov, A., Gaucher, É., & Perreault, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400871 · Cited by 38
Dendritic cells in hematological malignancies
Galati, D., Corazzelli, G., Filippi, R. D., & Pinto, A. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.10.006 · Cited by 37
Bolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis
Pahari, S., Kaur, G., Aqdas, M., Negi, S., Chatterjee, D., Bashir, H., Singh, S., & Agrewala, J. N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00906 · Cited by 37
Soleto, I., Fischer, U., Tafalla, C., & Granja, A. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00059 · Cited by 36
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
Amon, L., Hatscher, L., Heger, L., Dudziak, D., & Lehmann, C. H. K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070663 · Cited by 37
Defining Immunogenic and Radioimmunogenic Tumors
Medler, T. R., Blair, T. C., Crittenden, M. R., & Gough, M. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.667075 · Cited by 38
Huang, K., Matsumura, H., Zhao, Y., Herbig, M., Yuan, D., Mineharu, Y., Harmon, J., Findinier, J., Yamagishi, M., Ohnuki, S., et al. (2022) · Lab on a Chip · doi:10.1039/d1lc01043c · Cited by 38
Hatton, O., Lambert, S. L., Krams, S., & Martinez, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042610 · Cited by 35
Lozza, L., Farinacci, M., Bechtle, M., Stäber, M., Zedler, U., Baiocchini, A., Nonno, F. D., & Kaufmann, S. H. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00324 · Cited by 39
Hanč, P., Schulz, O., Fischbach, H., Martin, S. R., Kjær, S., & Sousa, C. R. E. (2016) · The EMBO Journal · doi:10.15252/embj.201694695 · Cited by 35
Self-citationEnders, M., Franken, L., Philipp, M., Kessler, N., Baumgart, A., Eichler, M., Wiertz, E. J. H. J., Garbi, N., & Kurts, C. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900021 · Cited by 35
Vitamin A and dendritic cell differentiation
Beijer, M. R., Kraal, G., & den Haan, J. M. M. (2013) · Immunology · doi:10.1111/imm.12228 · Cited by 35
The evolving biology of cross-presentation
Ohara, R. A., & MURPHY, K. M. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101711 · Cited by 37
Primary sterile necrotic cells fail to cross-prime CD8+T cells
Gamrekelashvili, J., Ormandy, L. A., Heimesaat, M. M., Kirschning, C. J., Manns, M. P., Korangy, F., & Greten, T. F. (2012) · OncoImmunology · doi:10.4161/onci.21098 · Cited by 36
Genealogy, Dendritic Cell Priming, and Differentiation of Tissue-Resident Memory CD8+ T Cells
Enamorado, M., Khouili, S. C., Iborra, S., & Sancho, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01751 · Cited by 37
Self-citationLi, X., Wang, X., Qian, G., & Ito, A. (2019) · Applied Materials Today · doi:10.1016/j.apmt.2019.05.006 · Cited by 34
Lubin, R., Patel, A. A., Mackerodt, J., Zhang, Y., Gvili, R., Mulder, K., Dutertre, C., Jalali, P., Glanville, J., Hazan, I., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20220867 · Cited by 32
Extracorporeal photopheresis for the treatment of autoimmune diseases
Adamski, J., Kinard, T. N., Ipe, T. S., & Cooling, L. L. W. (2015) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2015.02.005 · Cited by 33
Pearson, F. E., Tullett, K. M., Rojas, I. L., Haigh, O. L., Masterman, K., Walpole, C., Bridgeman, J. S., McLaren, J. E., Ladell, K., Miners, K. L., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1141 · Cited by 33
Role of Dendritic Cell in Diabetic Nephropathy
Kim, H., Kim, M., Lee, H. Y., Park, H., Jhun, H., & Kim, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147554 · Cited by 34
Beijer, M. R., Molenaar, R., Goverse, G., Mebius, R. E., Kraal, G., & den Haan, J. M. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343325 · Cited by 33
Nguyen, N. T., Le, X. T., Lee, W. T., Lim, Y. T., Oh, K. T., Lee, E. S., Choi, H., & Youn, Y. S. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.002 · Cited by 32
Evolution of B Cell Responses to Clec9A-Targeted Antigen
Park, H., Light, A., Lahoud, M. H., Caminschi, I., Tarlinton, D. M., & Shortman, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301947 · Cited by 32
PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF
Goyal, G., Wong, K. K. W., Nirschl, C. J., Souders, N. C., Neuberg, D. S., Anandasabapathy, N., & Dranoff, G. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0612 · Cited by 32
C‐type lectin receptors in antifungal immunity: Current knowledge and future developments
Hatinguais, R., Willment, J. A., & Brown, G. D. (2022) · Parasite Immunology · doi:10.1111/pim.12951 · Cited by 33
Peptidases released by necrotic cells control CD8+ T cell cross-priming
Gamrekelashvili, J., Kapanadze, T. G., Han, M., Wissing, J. B., Ma, C., Jaensch, L., Manns, M. P., Armstrong, T. D., Jaffee, E. M., White, A. O., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65698 · Cited by 33
Gonzales, G. A., Huang, S., Wilkinson, L., Nguyen, J. A., Sikdar, S., Piot, C., Naumenko, V., Rajwani, J., Wood, C. M., Dinh, I., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adn2168 · Cited by 29
New generation of dendritic cell vaccines
Radford, K. J., & Caminschi, I. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22487 · Cited by 31
Intracellular events regulating cross-presentation
Wagner, C., Grotzke, J. E., & Cresswell, P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00138 · Cited by 35
Streng‐Ouwehand, I., Ho, N. I., Litjens, M., Kalay, H., Boks, M. A., Cornelissen, L. A. M., Singh, S., Saeland, E., García-Vallejo, J. J., OSSENDORP, F. A., et al. (2016) · eLife · doi:10.7554/elife.11765 · Cited by 31
Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
Picco, G., Beatson, R., Taylor‐Papadimitriou, J., & Burchell, J. (2014) · European Journal of Immunology · doi:10.1002/eji.201344076 · Cited by 31
Elpek, K. G., Bellemare‐Pelletier, A., Malhotra, D., Reynoso, E. D., Lukacs‐Kornek, V., DeKruyff, R. H., & Turley, S. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023921 · Cited by 34
Legein, B., Janssen, E. M., Theelen, T. L., Gijbels, M. J., Walraven, J., Klarquist, J. S., Hennies, C. M., Wouters, K., Seijkens, T. T. P., Wijnands, E., et al. (2015) · Scientific Reports · doi:10.1038/srep15414 · Cited by 30
Tullett, K. M., Tan, P. S., Park, H., Schittenhelm, R. B., Michael, N., Li, R., Policheni, A. N., Gruber, E., Huang, C., Fulcher, A. J., et al. (2020) · eLife · doi:10.7554/elife.63452 · Cited by 30
Identification of a chicken CLEC-2 homologue, an activating C-type lectin expressed by thrombocytes
Neulen, M.-L., & Göbel, T. (2011) · Immunogenetics · doi:10.1007/s00251-011-0591-z · Cited by 30
NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death
O’Donnell, M. A., & Ting, A. T. (2012) · Immunologic Research · doi:10.1007/s12026-012-8321-7 · Cited by 31
Metadata
- Authors
- Sancho, D., Joffre, O. P., Keller, A. M., Rogers, N. C., Martínez, D., Hernanz-Falcón, P., Rosewell, I., & Sousa, C. R. E.
- Affiliations
- The Honourable Society of Lincoln's Inn (GB)
- Cancer Research UK (GB)
- Corresponding author
- Sousa, Caetano Reis e
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7240
- Pages
- 899-903
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2671489
- OpenAlex
- W2136883776
- Cited by
- 750
- References
- 27
- Citations by year
- 2026: 17 · 2025: 35 · 2024: 31 · 2023: 44 · 2022: 45 · 2021: 39 · 2020: 44 · 2019: 38 · 2018: 37 · 2017: 30 · 2016: 47 · 2015: 49 · 2014: 54 · 2013: 55 · 2012: 61
- FWCI
- 26.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Cancer Research UK (A3598)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- CLEC9A, DNGR-1, C-type lectin receptors, dendritic cells, CD8α+ dendritic cells, necrosis, cross-presentation, Syk, immunogenicity, tissue repair, inflammation, allograft rejection, tumor rejection
- MeSH terms
- Animals, Cells, Cultured, Dendritic Cells, Humans, Ligands, Necrosis, Phagocytosis, Receptors, Immunologic, Receptors, Mitogen, Signal Transduction, CD8 Antigens, CD8-Positive T-Lymphocytes, Lectins, C-Type, Cross-Priming, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
